“…As a rare bacterium, K. gyiorum gradually became resistant to some antibiotics, such as piperacillin/tazobactam, cefepime, ceftazidime, trimethoprim-sulfamethoxazole, gentamicin, aztreonam, fosfomycin, and colistin. 12 – 14 Fluoroquinolones penetrate bacterial cells through outer membrane porin and phospholipid, and induce changes in the configuration of enzymes, inhibit enzyme activity, and eventually lead to bacterial DNA degradation and cell death. 15 Under the action of fluoroquinolones, bacteria develop drug resistance through chromosomal gene mutation or a plasmid-mediated mechanism, including target site change, decreased membrane permeability, and drug inactivation.…”